Literature DB >> 24670135

Weighting with the Lansbury articular index improves the correlation of ultrasound score with serum matrix metalloproteinase-3 level in rheumatoid arthritis patients.

Misa Gorai1, Michihiro Ogasawara, Yuko Matsuki, Yusuke Yamada, Go Murayama, Nagachika Sugisaki, Takuya Nemoto, Seiichiro Ando, Kentaro Minowa, Takayuki Kon, Kurisu Tada, Masakazu Matsushita, Ken Yamaji, Naoto Tamura, Yoshinari Takasaki.   

Abstract

OBJECTIVE: To determine whether weighting improves the correlation of ultrasound (US) score with serum matrix metalloproteinase-3 (MMP-3) level in rheumatoid arthritis (RA).
METHODS: As ultrasound examination was performed on 100 RA patients, and the severity of synovial effusion and synovial hypertrophy and the blood flow were semi-quantitatively graded from 0 to 3 by using the gray-scale (GS) and power Doppler (PD) modes. We then calculated the sums of the scores of the 28 joints of each patient in the 2 modes, that is, the GS28 and PD28 scores, as well as the respective scores weighted using the Lansbury articular index (LAI, shoulder and elbow, × 12; wrist, × 8; and knee, × 24)-Lans GS28 and Lans PD28 scores. RESULT: The Lans PD28 score showed a higher correlation with MMP-3 (r = 0.591; 95% confidence interval, 0.446-0.705, p < 0.0001) than the existing measures. The scores of the large joints-the knee, shoulder, and elbow-correlated well with the serum MMP-3 level.
CONCLUSION: Weighting with the LAI can improve the correlation of US findings with serum MMP-3 level. Bidirectional approach based on both serum MMP-3 level and US scores can further improve the assessment of disease activity in RA patients.

Entities:  

Keywords:  Lansbury articular index; Matrix metalloproteinase-3; Rheumatoid arthritis; Ultrasound

Mesh:

Substances:

Year:  2014        PMID: 24670135     DOI: 10.3109/14397595.2014.888794

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  3 in total

1.  Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.

Authors:  Yuichi Maeda; Toru Hirano; Kosuke Ebina; Ryota Hara; Motomu Hashimoto; Wataru Yamamoto; Kosaku Murakami; Takuya Kotani; Kenichiro Hata; Yonsu Son; Hideki Amuro; Akira Onishi; Sadao Jinno; Masaki Katayama; Atsushi Kumanogoh
Journal:  Rheumatol Int       Date:  2021-04-26       Impact factor: 2.631

2.  Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis.

Authors:  Ling Zhou; Geng Wang; Xin Liu; Jing Song; Ling Chen; Huji Xu
Journal:  Arthritis Res Ther       Date:  2017-11-15       Impact factor: 5.156

3.  Serum matrix metalloproteinase 3 in detecting remitting seronegative symmetrical synovitis with pitting edema syndrome: A case report.

Authors:  Tsuneaki Kenzaka; Ken Goda
Journal:  World J Clin Cases       Date:  2018-05-16       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.